Showing results (1221-1230 of 1,314) with videos related to

Sort By:
Pageof 132
Journal of Experimental Botany|August 1, 2023
Diversity and genetic architecture of agro-morphological traits in a core collection of European traditional tomatoClara Pons, Joan Casals, Matthijs Brower, et al.
ACS Chemical Biology|January 10, 2023
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic PathwayChristopher T Saeui, Sagar R Shah, Beatriz I Fernandez-Gil, et al.
Cureus|June 7, 2018
A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic MalignanciesKathryn Mittauer, Bhudatt Paliwal, Patrick Hill, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2018
Including ELSI research questions in newborn screening pilot studiesAaron J Goldenberg, Michele Lloyd-Puryear, Jeffrey P Brosco, et al.
BMC Gastroenterology|November 18, 2022
Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C)Pulak Goswami, Oladapo R Adeniran, Shelby K Frantz, et al.
Nature Communications|April 26, 2023
Mini-PCDH15 gene therapy rescues hearing in a mouse model of Usher syndrome type 1FMaryna V Ivanchenko, Daniel M Hathaway, Alex J Klein, et al.
Annals of Surgery|February 15, 2001
Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patientsC W Hendrix, J M Hammond, S M Swoboda, et al.
Blood Advances|July 23, 2024
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucelNausheen Ahmed, William Wesson, Forat Lutfi, et al.
Blood Advances|November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapyKitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
Blood Advances|June 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium AnalysisKitsada Wudhikarn, Maria Bromberg, Jamie Brower, et al.
Pageof 132